Treatment with benfotiamine in patients with diabetic sensorimotor polyneuropathy: A double-blind, randomized, placebo-controlled, parallel group pilot study over 12 months

被引：4
|
作者：
Stirban, Ovidiu Alin [1 ]
Zeller-Stefan, Helga [2 ]
Schumacher, Jochen [2 ]
Gaus, Wilhelm [3 ]
Ziegler, Dan [4 ,5 ]
Schuerholz, Thomas [6 ,7 ]
Pop-Busui, Rodica [8 ]
机构：
[1] Internist Fachklin Dr Steger, Philipp Kittler Str 27, D-90480 Nurnberg, Germany
[2] Diabet Zentrum, Essen, Germany
[3] Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany
[4] Heinrich Heine Univ, Leibniz Ctr Diabet Res, German Diabet Ctr DDZ, Inst Clin Diabetol, Dusseldorf, Germany
[5] Heinrich Heine Univ, Med Fac, Div Endocrinol & Diabetol, Dusseldorf, Germany
[6] Worwag Pharma GmbH & Co KG, Boblingen, Germany
[7] InnoDiab Forsch GmbH, Essen, Germany
[8] Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF DIABETES AND ITS COMPLICATIONS | 2020年 / 34卷 / 12期
关键词：
Benfotiamine; Diabetic neuropathy; Treatment;
D O I：
10.1016/j.jdiacomp.2020.107757
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Benfotiamine in Diabetic Polyneuropathy (BENDIP): Results of a Randomised, Double Blind, Placebo-controlled Clinical Study
    Stracke, H.
    Gaus, W.
    Achenbach, U.
    Federlin, K.
    Bretzel, R. G.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2008, 116 (10) : 600 - 605
  • [2] BOND study: a randomised double-blind, placebo-controlled trial over 12 months to assess the effects of benfotiamine on morphometric, neurophysiological and clinical measures in patients with type 2 diabetes with symptomatic polyneuropathy
    Boenhof, Gidon J.
    Sipola, Gundega
    Strom, Alexander
    Herder, Christian
    Strassburger, Klaus
    Knebel, Birgit
    Reule, Claudia
    Wollmann, Jan-Christoph
    Icks, Andrea
    Al-Hasani, Hadi
    Roden, Michael
    Kuss, Oliver
    Ziegler, Dan
    BMJ OPEN, 2022, 12 (02):
  • [3] CYCLANDELATE IN DIABETIC NEUROPATHY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, CROSS-OVER STUDY
    HEIMANS, JJ
    DRUKARCH, B
    MATTHAEI, I
    IJFF, GA
    BERTELSMANN, FW
    STRIJERS, RLM
    NAUTA, J
    ACTA NEUROLOGICA SCANDINAVICA, 1991, 84 (06): : 483 - 486
  • [4] Double-blind, randomized placebo-controlled clinical trial of benfotiamine for severe alcohol dependence
    Manzardo, Ann M.
    He, Jianghua
    Poje, Albert
    Penick, Elizabeth C.
    Campbell, Jan
    Butler, Merlin G.
    DRUG AND ALCOHOL DEPENDENCE, 2013, 133 (02) : 562 - 570
  • [5] GANGLIOSIDES IN THE TREATMENT OF DIABETIC NEUROPATHY - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDING STUDY
    LINGETTI, M
    COTO, V
    RENGO, F
    SGAMBATO, S
    INNOCENTI, A
    FIORI, MG
    DIABETES NUTRITION & METABOLISM, 1992, 5 (04) : 275 - 282
  • [6] Treatment of rheumatoid arthritis with ornidazole: a randomized, double-blind, placebo-controlled study
    Ogrendik, Mesut
    RHEUMATOLOGY INTERNATIONAL, 2006, 26 (12) : 1132 - 1137
  • [7] Treatment of rheumatoid arthritis with ornidazole: a randomized, double-blind, placebo-controlled study
    Mesut Ogrendik
    Rheumatology International, 2006, 26 : 1132 - 1137
  • [8] A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Rett Syndrome
    Glaze, Daniel G.
    Neul, Jeffrey. L.
    Percy, Alan
    Feyma, Tim
    Beisang, Arthur
    Yaroshinsky, Alex
    Stoms, George
    Zuchero, David
    Horrigan, Joseph
    Glass, Larry
    Jones, Nancy E.
    PEDIATRIC NEUROLOGY, 2017, 76 : 37 - 46
  • [9] Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials
    Thienel, U
    Neto, W
    Schwabe, SK
    Vijapurkar, U
    ACTA NEUROLOGICA SCANDINAVICA, 2004, 110 (04): : 221 - 231
  • [10] TREATMENT OF FIBROMYALGIA SYNDROME WITH SUPER MALIC(R) - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER PILOT-STUDY
    RUSSELL, IJ
    MICHALEK, JE
    FLECHAS, JD
    ABRAHAM, GE
    JOURNAL OF RHEUMATOLOGY, 1995, 22 (05) : 953 - 958
12345